• Episode 34: The Risks of Polypharmacy: A Guide for Speech-Language Pathologists

  • Jun 20 2024
  • Duración: 1 h y 3 m
  • Podcast

Episode 34: The Risks of Polypharmacy: A Guide for Speech-Language Pathologists  Por  arte de portada

Episode 34: The Risks of Polypharmacy: A Guide for Speech-Language Pathologists

  • Resumen

  • Guest: Lisa Milliken, MA, CCC-SLP, FNAP, CDP, RAC- CT, CADDCT - In this episode, Renee is joined by Lisa to discuss the impacts of polypharmacy and explore the pathophysiological changes behind drug-induced cognitive impairment, which sheds light on the complexities of this condition. Determining when Post-operative Cognitive Dysfunction (POCD) poses a significant risk is crucial for patient care and recovery, as is understanding how aging changes impact adverse medication reactions. In this episode, join Renee and Lisa as we delve into these topics to enhance our understanding and awareness of cognitive health in medical contexts.
    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Episode 34: The Risks of Polypharmacy: A Guide for Speech-Language Pathologists

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.